SCHEMBL30656274

SCHEMBL30656274

Cc1sc2ccc(OCc3cccnc3O)cc2c1C(=O)NC1(CO)CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 3/20 0.41
MMP3 P08254 2/20 0.41
MMP7 P09237 2/20 0.41
ADAMTS4 O75173 1/20 0.41
ADAMTS1 Q9UHI8 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
CNR2 P34972 2/20 0.40
CD274 Q9NZQ7 1/20 0.39
BTK Q06187 1/20 0.39
MMP2 P08253 1/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
DGAT2 Q96PD7 3/20 0.37
ANO1 Q5XXA6 5/20 0.36
CNR1 P21554 1/20 0.33
SLC26A4 O43511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656121 0.93 CNR2 (0.38) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656046 0.91 CD274 (0.41) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656015 0.89 ADAM17 (0.39) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656334 0.89 CYP4F2 (0.40) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656223 0.87 BTK (0.42) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656068 0.87 MMP13 (0.42) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656232 0.85 KDM4E (0.43) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656112 0.84 CD274 (0.35) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656102 0.83 MMP3 (0.38) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30656330 0.83 CD274 (0.37) ADAM17MMP3MMP7ADAMTS4ADAMTS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed